Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656564 · ClinicalTrials.gov registry record
Clinical Outcomes of People Who Acquired HIV in Early Life
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 177
- Enrollment target
NCT01656564 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 177 participants.
The verdict
NCT01656564 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 177 participants
- Enrollment target
Study Summary
Background: \- Long-term survival with the human immunodeficiency virus (HIV) is not well understood. Adults who were infected with HIV as children have lived with the virus for many years. However, the effect of HIV on this group of people has not been studied in depth. Researchers are interested in studying how HIV infection and the medicines used to treat it affect people who were infected early in life. They want to find out if there are any problems with how HIV-infected children grow and develop as adults, especially if they have developed heart problems. As part of this study, people with HIV will be compared with healthy volunteers. Objectives: \- To study the effect of HIV infection and treatment on people who acquired HIV infection in early life. Eligibility: * Individuals at least 18 years of age who acquired HIV infection in early life. * Healthy volunteers at least 18 years of age without HIV will serve as controls Design: * Participants will be screened with a physical exam and medical history. They will have regular study visits about once a year for up to 10 years to collect health information. * Blood and urine samples will be collected to look at kidney and liver function. * X-ray scans will be used to look at bone density and the amount of fat and muscle in the body. * Treatment will not be provided as part of this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2012-08-27 |
| Est. Completion | 2023-03-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01656564
The ClinicalTrials.gov registry entry for NCT01656564 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01656564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01656564 about?
NCT01656564 is a clinical study titled "Clinical Outcomes of People Who Acquired HIV in Early Life". Background: \- Long-term survival with the human immunodeficiency virus (HIV) is not well understood. Adults who were infected with HIV as children have lived with the virus for many years. However, the effect of HIV on this group of people has not been studied in depth. Researchers are interested ...
What is the current status of trial NCT01656564?
This trial is currently completed. The enrollment target is 177 participants. The study started on 2012-08-27. Estimated completion is 2023-03-08.
Who is sponsoring clinical trial NCT01656564?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.